scholarly article | Q13442814 |
P2093 | author name string | Lesley E Scott | |
Linda Erasmus | |||
Wendy Stevens | |||
Willem D F Venter | |||
Jackie Moloi | |||
Lara D Noble | |||
P2860 | cites work | Measuring agreement in method comparison studies | Q28145208 |
Molecular beacons: probes that fluoresce upon hybridization | Q28274024 | ||
HIV-1 viral load assays for resource-limited settings | Q33259966 | ||
Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa | Q33824797 | ||
Diagnosis of HIV infection and laboratory monitoring of its therapy | Q34277009 | ||
Improved HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma | Q34419917 | ||
How many people are currently infected with HIV in South Africa? | Q34663512 | ||
Characteristics of the m2000 automated sample preparation and multiplex real-time PCR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae | Q35690738 | ||
Evaluation of the performance of the automated NucliSENS easyMAG and EasyQ systems versus the Roche AmpliPrep-AMPLICOR combination for high-throughput monitoring of human immunodeficiency virus load | Q35784400 | ||
Molecular assays for monitoring HIV infection and antiretroviral therapy | Q36816024 | ||
Thermodynamic basis of the enhanced specificity of structured DNA probes | Q37200381 | ||
Quantification of HIV-1 group M (subtypes A-G) and group O by the LCx HIV RNA quantitative assay | Q38885775 | ||
Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5' long terminal repeat domain | Q38978220 | ||
Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa | Q39753822 | ||
Scaling up ART treatment capacity: lessons learned from South Africa, Zimbabwe, and Botswana | Q40798969 | ||
Multicenter performance evaluation of a new TaqMan PCR assay for monitoring human immunodeficiency virus RNA load | Q41072830 | ||
Comparative evaluation of the automated Roche TaqMan real-time quantitative human immunodeficiency virus type 1 RNA PCR assay and the Roche AMPLICOR Version 1.5 conventional PCR assay | Q42030505 | ||
Thermodynamically modulated partially double-stranded linear DNA probe design for homogeneous real-time PCR | Q42160975 | ||
Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT | Q42211051 | ||
Comparative evaluation of the performance of the Abbott real-time human immunodeficiency virus type 1 (HIV-1) assay for measurement of HIV-1 plasma viral load following automated specimen preparation | Q42408684 | ||
Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays | Q42637939 | ||
Comparison of the Roche COBAS Amplicor Monitor, Roche COBAS Ampliprep/COBAS Taqman and Abbott RealTime Test assays for quantification of hepatitis C virus and HIV RNA. | Q43039006 | ||
Evaluation of the analytical performance of the new Abbott RealTime RT-PCRs for the quantitative detection of HCV and HIV-1 RNA. | Q43040408 | ||
Evaluation of the NucliSens EasyQ assay in HIV-1-infected individuals in South Africa | Q43682159 | ||
Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes | Q45052445 | ||
Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system | Q45406680 | ||
Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays--LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) an | Q45423609 | ||
Comparative performance of the Amplicor HIV-1 Monitor Assay versus NucliSens EasyQ in HIV subtype C-infected patients | Q46713961 | ||
Increased levels of HIV RNA detected in samples with viral loads close to the detection limit collected in Plasma Preparation Tubes (PPT). | Q46777621 | ||
Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization | Q46960543 | ||
Multiple method comparison: statistical model using percentage similarity | Q47802478 | ||
Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine. | Q51081557 | ||
Evaluation of performance across the dynamic range of the Abbott RealTime HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses. | Q51092043 | ||
Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from London: comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx HIV RNA Quantitative assays. | Q51154109 | ||
Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma. | Q51467024 | ||
Partially double-stranded linear DNA probes: novel design for sensitive detection of genetically polymorphic targets. | Q53573165 | ||
Quantitative measurement of HIV RNA: techniques & clinical applications. | Q54014878 | ||
Appropriate laboratory monitoring of HIV. | Q54058667 | ||
Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from Brazil. | Q54615727 | ||
Monitoring HIV viral loads in the United States: recent trends and methodologies | Q74230694 | ||
Assay of plasma samples representing different HIV-1 genetic subtypes: an evaluation of new versions of the amplicor HIV-1 monitor assay | Q78008158 | ||
Performance of the Abbott RealTime HIV-1 assay for quantification of HIV-1 clades prevalent in China | Q80804384 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | South Africa | Q258 |
HIV | Q15787 | ||
P304 | page(s) | 2209-2217 | |
P577 | publication date | 2009-05-06 | |
P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
P1476 | title | Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSEN | |
P478 | volume | 47 |
Q35189996 | Abbott RealTime HIV-1 m2000rt viral load testing: manual extraction versus the automated m2000sp extraction |
Q94570568 | Accurate HIV viral load measurement in primary health care settings using the cobas® plasma separation card |
Q35273824 | An international collaboration to standardize HIV-2 viral load assays: results from the 2009 ACHI(E)V(2E) quality control study |
Q33647158 | Clinical and Mucosal Immune Correlates of HIV-1 Semen Levels in Antiretroviral-Naive Men. |
Q34547246 | Comparative evaluation of the performance of the Abbott RealTime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from Greece |
Q84380599 | Comparison of HIV-1 viral load assay performance in immunological stable patients with low or undetectable viremia |
Q37050729 | Comparison of the Abbott m2000 HIV-1 Real-Time and Roche AMPLICOR Monitor v1.5 HIV-1 assays on plasma specimens from Rakai, Uganda |
Q34487510 | Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for determination of HIV-1 viral loads in a cohort of Canadian patients with diverse HIV subtype infections |
Q34301929 | Cross-platform analysis of HIV-1 RNA data generated by a multicenter assay validation study with wide geographic representation |
Q38088726 | Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1. |
Q92570580 | Early infant diagnosis HIV-1 PCR cycle-threshold predicts infant viral load at birth |
Q38417936 | Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification |
Q36173963 | Evaluation of the RealTime HIV-1, Xpert HIV-1, and Aptima HIV-1 Quant Dx Assays in Comparison to the NucliSens EasyQ HIV-1 v2.0 Assay for Quantification of HIV-1 Viral Load |
Q42113208 | HIV-1 Load Comparison Using Four Commercial Real-Time Assays |
Q64108555 | Impact of Herpes Simplex Virus Type 2 and Human Immunodeficiency Virus Dual Infection on Female Genital Tract Mucosal Immunity and the Vaginal Microbiome |
Q30248647 | Laboratory Innovation Towards Quality Program Sustainability |
Q36228238 | Options to Expand HIV Viral Load Testing in South Africa: Evaluation of the GeneXpert® HIV-1 Viral Load Assay |
Q36779718 | Past, present and future molecular diagnosis and characterization of human immunodeficiency virus infections. |
Q47909581 | Prospective evaluation of a new automated nucleic acid extraction system using routine clinical respiratory specimens |
Q37217809 | Relationship between chemokine receptor expression, chemokine levels and HIV-1 replication in the lungs of persons exposed to Mycobacterium tuberculosis |
Q35099443 | Systematic review of the performance of HIV viral load technologies on plasma samples |
Q35802992 | The impact on blood donor screening for human immunodeficiency virus, hepatitis C virus, and hepatitis B virus using plasma from frozen-thawed plasma preparation tubes |
Q35551811 | Theoretical design and analysis of multivolume digital assays with wide dynamic range validated experimentally with microfluidic digital PCR |
Q36414140 | Use of a prequalification panel for rapid scale-up of high-throughput HIV viral load testing. |